Murray, Benjamin S.Dyson, Paul Joseph2020-07-092020-07-092020-07-092019-12-0510.1016/j.cbpa.2019.11.001https://infoscience.epfl.ch/handle/20.500.14299/169952From their early successes in medicine, organometallic compounds continue to attract interest as potential chemotherapeutics to treat a range of diseases. Here, we show from recent literature selected largely from the last two years that organometallics offer unique opportunities in medicine and, increasingly, a mechanistic-based approach is applied to their development, which has not always been the case.Bioorganometallic chemistryBioinorganic chemistryMetallodrugsChemotherapytext::journal::journal article::research article